Insights Care: The Power Players—CRO Leaders Redefining the Industry in 2024
CNS-Targeted Therapies Delivery Strategies and Sampling in Non-rodent Preclinical Species: Considerations During Early Phase Discovery to IND-Enabling Regulatory Studies
Simpler Clinical Development From Day Dot
Connecting the Dots With Comprehensive CRO Solutions
When you CONNECT THE DOTS, you open a world of possibilities.
At Altasciences, we connect the dots, so you don’t have to. With you in mind, we establish a clear and consistent path from drug discovery to delivery—one solution seamlessly connecting to the next. All you have to do is reach out and get the conversation started.
Ready for a simpler drug development journey? Contact us today.
You may also be interested in these resources:
- Webpage: Clinical Research Support Services
- Video: Clinical Trial Site Identification, Selection, and Management
- Fact Sheet: Integrated Research Support Services
Pharma Tech Outlook: Top 20 CROs of 2024
Development of the Subject-Rated Comprehensive Drug Withdrawal Scale (CDWS) to Evaluate the Physical Dependence Potential of Investigational Drugs
Pragmatic Considerations for the Application of Physical Withdrawal Assessments in Patient Studies
Getting to the Heart of Science with Sophie Dubois
The Stories That Inspire
In this video, our very own Sophie Dubois shares what led her to Altasciences and how the company’s core values and mission of helping to improve lives resonate with her.
Struggling With Solubility or Bioavailability Challenges?
Trust the Right Formulation Partner.
Altasciences’ scientists have formulated and developed countless molecules using various advanced technologies. We solve the most complex solubility and bioavailability challenges using superior, data-driven technologies, such as nanomilling.
Our full range of pharmaceutical formulation services can improve the quality and performance of your product, for a seamless transition from discovery to clinical trials to market.
Ready to start? Speak with one of our experts, and let us help you deliver better treatments to patients who need them, faster.
Related resources that may interest you:
Up Close and Personal With Ashley (Schnider) Mahoney, Study Director, Scientist
Ashley joined Altasciences in 2022 as Study Director.